The goal of BioPredictive is the discovery and development of new non-invasive diagnostic tests which aim to improve the management of liver disease.
After FibroTest-ActiTest's launch in 2002, which has since turned out to be the reference in its field, once again BioPredictive breaks new groung with the SteatoTest, the NashTest, the AshTest and the FibroMAX.